Canada
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Canada
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program
Psychedelics
Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership
Canada
Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT
Psychedelics
Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance
Business
The psilocybin producer will be working with the Knowde Group, Inc., BC Green Pharmaceuticals Inc. and Promises Innovative Recovery (PIR)
Canada
Application follows successful pre-clinical animal studies at the University of Arkansas
Canada
Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency
Psychedelics
Biopharmaceutical company administers optimized form of LSD in Phase 2b dose-optimization trial
Psychedelics
New York law firm forms multidisciplinary association intended to serve the psychedelic industry
